171 related articles for article (PubMed ID: 33574829)
1. Evaluation of Maternal Serum sHLA-G Levels for Trisomy 18 Fetuses Screening at Second Trimester.
Xu D; Zhu Y; Li L; Xu Y; Yan W; Dai M; Gan L
Front Genet; 2020; 11():497264. PubMed ID: 33574829
[TBL] [Abstract][Full Text] [Related]
2. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
Hu Z; Liu X; Li L; Jia C; Li D; Liu R
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
[TBL] [Abstract][Full Text] [Related]
3. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
4. [Early warning of low maternal unconjugated estriol level by prenatal screening for fetus with X-linked ichthyosis].
Liu HY; Li J; Huang DR; Feng K; Liu JH; He QN; Guo KY; Ding GY; Lou Y; Wang Y
Zhonghua Fu Chan Ke Za Zhi; 2022 Jun; 57(6):407-412. PubMed ID: 35775247
[No Abstract] [Full Text] [Related]
5. Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18.
Chen Y; Chen Y; Ning W; Zhang W; Li L; Wang X; Yin Y; Zhang H
Sci Rep; 2022 Aug; 12(1):13605. PubMed ID: 35948592
[TBL] [Abstract][Full Text] [Related]
6. A risk prediction model for fetal hypospadias by testing maternal serum AFP and free beta-HCG.
Chen Y; Huang J; Mei J
Clin Biochem; 2019 Jul; 69():21-25. PubMed ID: 31152694
[TBL] [Abstract][Full Text] [Related]
7. [The value of maternal first and second trimester serum data of β-hCG, PAPP-A, AFP and uE3 in the prediction of preeclampsia].
Gu W; Lin J; Hou Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):101-7. PubMed ID: 25877605
[TBL] [Abstract][Full Text] [Related]
8. A retrospective evaluation of second-trimester serum screening for fetal trisomy 18: experience of two laboratories.
Sancken U; Bartels I; Louwen F; Eiben B
Prenat Diagn; 1999 Oct; 19(10):947-54. PubMed ID: 10521821
[TBL] [Abstract][Full Text] [Related]
9. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
[TBL] [Abstract][Full Text] [Related]
10. The usefulness of hCG and unconjugated oestriol in prenatal diagnosis of trisomy 18.
Leporrier N; Herrou M; Herlicoviez M; Leymarie P
Br J Obstet Gynaecol; 1996 Apr; 103(4):335-8. PubMed ID: 8605130
[TBL] [Abstract][Full Text] [Related]
11. External Quality Assessment of Maternal Serum Levels of Alpha-Fetoprotein, Free Beta-Human Chorionic Gonadotropin, and Unconjugated Estriol in Detecting Down Syndrome and Neural Tube Defects in the Second Trimester of 87 Maternal Serum Samples, Based on 105-139 Days.
Chen Y; Chen Y; Shi Y; Ning W; Wang X; Li L; Zhang H
Med Sci Monit; 2022 Apr; 28():e935573. PubMed ID: 35414638
[TBL] [Abstract][Full Text] [Related]
12. Association Analysis between Maternal Serum Biomarkers and Fetal Congenital Heart Disease.
Jiang H; Lin Y; He X
Heart Surg Forum; 2023 Oct; 26(5):E552-E559. PubMed ID: 37920073
[TBL] [Abstract][Full Text] [Related]
13. Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21.
Souter VL; Nyberg DA; El-Bastawissi A; Zebelman A; Luthhardt F; Luthy DA
Prenat Diagn; 2002 Mar; 22(3):175-82. PubMed ID: 11920888
[TBL] [Abstract][Full Text] [Related]
14. The use of free beta-hCG in antenatal screening for Down's syndrome.
Wald N; Densem J; Stone R; Cheng R
Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal abnormalities and adverse pregnancy outcome with maternal serum second trimester triple screening test for fetal Down syndrome in 4,860 Chinese women.
Xia YP; Zhu MW; Li XT; Zhou HP; Wang J; Lv JX; Zhong N
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 38(1):49-52. PubMed ID: 16415966
[TBL] [Abstract][Full Text] [Related]
16. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
17. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
18. Second trimester maternal serum markers and a predictive model for predicting fetal hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
J Matern Fetal Neonatal Med; 2013 Jan; 26(2):146-9. PubMed ID: 22989193
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of alpha-fetoprotein variants L2 and L3 as substitutes of alpha-fetoprotein in screening for fetal Trisomy 18.
Chen Y; Ning W; Wang H; Chen Y; Huang J; Wen L; Hu W
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6764-6769. PubMed ID: 33980109
[TBL] [Abstract][Full Text] [Related]
20. Second-trimester Maternal Serum Screening Biomarkers in the Risk Assessment for Preeclampsia.
Long W; Zhou Q; Wang H; Lu B; Chen Y; Zhang B; Zhou W; Yu B
Ann Clin Lab Sci; 2018 May; 48(3):308-313. PubMed ID: 29970433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
